This amendment (this “Amendment No. 1”) is filed on behalf of Kensington Capital Sponsor IV LLC (the “Sponsor”), Kensington Capital Partners, LLC and Justin Mirro.
This Amendment No. 1 amends the Schedule 13D originally filed with the Commission on March 18, 2022 (the “Original Schedule 13D”).
All terms used, but not defined, in this Amendment No. 1 are as defined in the Original Schedule 13D. The summary descriptions (if any) contained herein of certain agreements and documents are qualified in their entirety by reference to the complete text of such agreements and documents filed as Exhibits hereto or incorporated herein by reference.
Item 4. | Purpose of the Transaction |
Item 4 of the Original Schedule 13D is amended as follows:
Concurrently with the execution of the business combination agreement, dated as of May 11, 2022 (the “Business Combination Agreement”), among the Issuer, Kensington Capital Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of the Issuer, and Amprius Technologies, Inc., a Delaware corporation (the “Company”), the Sponsor, the Issuer, and the Company entered into a Sponsor Support Agreement, dated as of May 11, 2022 (the “Sponsor Support Agreement”), pursuant to which, among other things, the Sponsor reaffirmed its obligations in the Letter Agreement to vote in favor of each of the proposals to be voted upon at the meeting of the Issuer’s shareholders in connection with the business combination contemplated by the Business Combination Agreement, including approval of the Business Combination Agreement and the transactions contemplated thereby.
The description of the Sponsor Support Agreement is qualified in its entirety by reference to the full text of such agreement, a copy of which was filed by the Issuer as Exhibit 10.1 to the Form 8-K filed by the Issuer with the SEC on May 12, 2022 (and is incorporated by reference herein as Exhibit 10.4).
Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer |
Item 6 of the Original Schedule 13D is amended as follows:
The disclosure set forth in Item 4 of this Amendment No. 1 is incorporated into this Item 6 by reference.
Item 7. | Material to be Filed as Exhibits |
Item 7 of the Original Schedule 13D is amended as follows:
Exhibit 10.4 | Sponsor Support Agreement, dated as of May 11, 2022, by and among the Sponsor, the Issuer and the Company (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Issuer with the SEC on May 12, 2022). |
5